PHARMA EVIDENCE ApS: Financial statements 2014
CVR: 34586519
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 1,287,101 and a net result of DKK -236,941 compared with DKK 54,150 the year before. That is an increase of 44.3% compared with the year before. Equity in the 2014 report amounted to DKK 227,182. The solvency ratio was 26%.
- Gross Profit
- DKK 1,287,101
- Profit/Loss
- DKK -236,941
- Equity
- DKK 227,182
- Total Assets
- DKK 875,311
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 1.3 mio. | -237 t. | 227 t. | - |
| 2013 | - | 892 t. | 54 t. | 464 t. | - |
| 2012 | - | 868 t. | -448 t. | 410 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
PHARMA EVIDENCE ApS has published its annual report for 2013. Gross profit came to DKK 891,935, and the net result was DKK 54,150.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.